Clinical Trial Update: Phase II Study of RT-PEPC in Relapsed Mantle Cell Lymphoma [Phase 2]

View source ↗

Summary

A Phase II clinical trial evaluating the RT-PEPC regimen in relapsed mantle cell lymphoma has completed, with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mantle Cell Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• RT-PEPC

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Non-Hodgkin's Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2017-09-12